55359-96-1 Usage
General Description
5-Thiazolecarboxaldehyde, 4-chloro-2,3-dihydro-2-oxo- is a chemical compound with a thiazole structure and a chloro substitution at the 4-position. It is also known as 4-chloro-2,3-dihydrothiazole-4-carbaldehyde. 5-Thiazolecarboxaldehyde, 4-chloro-2,3-dihydro-2-oxo- is commonly used as a building block in organic synthesis and is a key intermediate in the production of pharmaceuticals, agrochemicals, and other fine chemicals. It is known to exhibit a range of biological activities and has been the subject of research for its potential medicinal and industrial applications. Its unique structure and reactivity make it a valuable component in the development of novel chemical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 55359-96-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,5,3,5 and 9 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 55359-96:
(7*5)+(6*5)+(5*3)+(4*5)+(3*9)+(2*9)+(1*6)=151
151 % 10 = 1
So 55359-96-1 is a valid CAS Registry Number.
InChI:InChI=1/C4H2ClNO2S/c5-3-2(1-7)9-4(8)6-3/h1H,(H,6,8)
55359-96-1Relevant articles and documents
First synthesis of novel aminophenyl pyridinium-5-(hydroxybenzoyl)-hydrazonomethyl-2-oxothiazol-3-ide derivatives and evaluation of their anticancer activities
Min, Dongguk,Han, Moon Hi,Lee, Seulki,Jung, Mankil
, p. 843 - 847 (2015/11/27)
The first total synthesis for large-scale production and anticancer activity of novel aminophenylpyridinium-5-(hydroxybenzoyl)hydrazonomethyl-2-oxothiazol-3-ide (PBHT) (1) and its derivatives are reported. The chemical structure of PBHT was unambiguously
3-β-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
-
Page/Page column 91; 92, (2010/02/15)
The invention is directed to 3-?-D-ribofuranosylthiazolo[4,5-d]pyridimine nucleosides and pharmaceutical compositions containing such compounds that have immunomodulatory activity. The invention is also directed to the therapeutic or prophylactic use of such compounds and compositions, and to methods of treating diseases and disorders described herein, by administering effective amounts of such compounds.